Camrelizumab for Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Camrelizumab for Injection, covering 2020-04-14 to 2020-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer [Phase 2]